More on BOCX
Financials
News
Click line-items for a historical chart and %
| Cash | 19.72K |
| Prepaid expenses and other | 4.68K |
| Total Current Assets | 24.4K |
| Debt issue costs (Note 4 (a) and 6 (b)) | 16.37K |
| Patents (Note 3) | 112.17K |
| Total Assets | 160.82K |
| Accounts payable | 156.87K |
| Derivative liability (Note 12) | 39.16K |
| Accrued liabilities | 379.96K |
| Loans payable (Note 4 (b)) | 306.47K |
| Due to related parties (Note 5) | 1.12M |
| Convertible notes payable (Note 6 (a)) | 549.16K |
| Total Current liabilities | 2.59M |
| Loans payable (Note 4 (a)) | |
| Convertible debt (Note 6 (b)) | 0 |
| Total liabilities | 2.59M |
| Stockholders' Equity (Deficit) | |
| Common stock Authorized: 450,000,000 shares, par value $0.001 Issued and outstanding:174,427,131 (December 31, 2010 – 168,188,974) | 307.26K |
| Additional paid-in capital | 25.44M |
| Accumulated deficit | -114.18K |
| Deficit accumulated during the development stage | -28.06M |
| Stockholders' Equity (Deficit) | -2.43M |
| Total Liabilities and Stockholders' Equity (Deficit) | 160.82K |
